NICE NG25: Preterm Labour and Birth

This is the current, actively-maintained NICE guideline on preterm labour and birth. For a general historical overview see rcog-gtg/preterm-labour-overview.md; for cervical cerclage technique and patient-selection detail specifically, see RCOG GTG 75.

Prediction of Preterm Birth

Transvaginal cervical length (TVUS): - A cervical length of 25 mm or less, measured between 16+0 and 24+0 weeks, identifies women at increased risk of preterm birth.

Diagnosing preterm labour in symptomatic women (intact membranes): - In women ≥30+0 weeks with symptoms of preterm labour, if cervical length on TVUS is 15 mm or less, regard the woman as being in diagnosed preterm labour. - Fetal fibronectin testing is used as an adjunct in symptomatic women: a concentration of 50 ng/ml or less suggests a low risk of birth within 48 hours; a concentration of more than 50 ng/ml is treated as diagnostic of preterm labour.

Prevention

Vaginal progesterone: - Offer to women with a history of spontaneous preterm birth (at or before 34+0 weeks) or a mid-trimester loss (from 16+0 weeks), and a cervical length of 25 mm or less on TVUS performed between 16+0 and 24+0 weeks. - Start between 16+0 and 24+0 weeks and continue until at least 34 weeks.

Cervical cerclage: - Offered to women meeting equivalent risk-factor and cervical-length criteria (history of spontaneous preterm birth/mid-trimester loss, or prior P-PROM/cervical trauma, with a short cervix on TVUS in the 16+0–24+0 week window). - NG25 covers the indication; RCOG GTG 75 is the corpus reference for cerclage technique (history-indicated vs ultrasound-indicated vs rescue), operative detail and removal timing.

Management of Established or Threatened Preterm Labour

Tocolysis: - 24+0–25+6 weeks, intact membranes: consider nifedipine. - 26+0–33+6 weeks, intact membranes: offer nifedipine. - If nifedipine is contraindicated, offer an oxytocin receptor antagonist (atosiban) instead. - Purpose is to delay birth long enough to complete corticosteroids and, if needed, arrange in-utero transfer — not to prolong pregnancy indefinitely.

Antenatal corticosteroids: - 22+0–23+6 weeks: discuss with the woman and her family, taking an individualised approach that accounts for survival and morbidity likelihood. - 24+0–33+6 weeks: offer a course of corticosteroids. - 34+0–35+6 weeks: consider a course. - Repeat course: a single repeat course may be considered for women under 34+0 weeks if the first course was given more than 7 days earlier and the woman is judged to be at very high risk of birth within the next 48 hours. - Do not give more than 2 courses in total.

Magnesium sulphate for fetal neuroprotection: - 23+0–23+6 weeks: discuss, with an individualised decision. - 24+0–29+6 weeks: offer, in established preterm labour or where planned preterm birth is anticipated within 24 hours. - 30+0–33+6 weeks: consider under the same circumstances. - Dosing: 4 g intravenous bolus over 15 minutes, followed by 1 g/hour by infusion until birth or for 24 hours — whichever is sooner.

High-Yield Exam Points

Short cervix threshold for offering vaginal progesterone or cerclage: TVUS cervical length ≤25 mm, measured at 16+0–24+0 weeks.
Diagnostic cervical length cut-off in symptomatic women ≥30+0 weeks: ≤15 mm = diagnosed preterm labour.
Fetal fibronectin: ≤50 ng/ml = low risk within 48h; >50 ng/ml = treated as diagnostic of preterm labour.
Nifedipine tocolysis: consider at 24+0–25+6 weeks, offer at 26+0–33+6 weeks; atosiban if nifedipine contraindicated.
Corticosteroids: offer 24+0–33+6 weeks; discuss at 22+0–23+6 weeks; consider at 34+0–35+6 weeks. Maximum of 2 courses ever, repeat course only if >7 days since the first and very high risk of birth within 48 hours.
Magnesium sulphate neuroprotection: offer 24+0–29+6 weeks, consider 30+0–33+6 weeks, discuss 23+0–23+6 weeks. Regimen: 4 g IV bolus over 15 minutes, then 1 g/hour until birth or for 24 hours, whichever is sooner.
This guideline was last formally reviewed in May 2023, with no further update currently planned — treat NG25 thresholds above as the current exam-relevant standard over any older recall figures.

Reference

NICE NG25. Preterm Labour and Birth. National Institute for Health and Care Excellence. Available at: https://www.nice.org.uk/guidance/ng25

Source: National Institute for Health and Care Excellence (NICE) (10 June 2022 (last reviewed 1 May 2023 — no update to recommendations planned unless new evidence emerges))

Read the original on nice.org.uk

Clinically reviewed by NHS obstetricians and gynaecologists · Source last updated 10 June 2022 (last reviewed 1 May 2023 — no update to recommendations planned unless new evidence emerges)

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).